Home LiteratureArticle Details
PMID: 6748113 Published · ppublish English Journal Article

Cerebral endogenous substrate utilization during the recovery period after profound hypoglycemia.

Journal of neuroscience research ·Vol. 11 ·No. 4 ·1984-00-00 ·Pages 437-50

Benzi G, Villa RF, Dossena M, Vercesi L, Gorini A, Pastoris O

Abstract

Markedly decreased levels of energy-rich phosphates were seen in cerebral cortex after severe hypoglycemia, followed by their partial restitution during the recovery period. During hypoglycemia the nonglucose endogenous substrates were provided by glycolytic intermediates, by Krebs cycle intermediates, and by related amino acids. Other potential substrates for brain oxidation were provided by the breakdown of phospholipids and fatty acids. After a 20-min period of posthypoglycemic recovery, partial restoration of carbohydrates and amino acids occurred, although the amino acid pool size was still reduced. The alterations in phospholipids and fatty acids persisted, while there was a tendency toward normalization of the free fatty acid content. During the posthypoglycemic recovery, treatment with some specific metabolic modulators (6-aminonicotinamide, hopantenate, uridine, L-acetylcarnitine) suggested the possibility of an alternative cerebral substrate utilization owing to modulation of the cerebral biochemical machinery. Thus, increased carbohydrate utilization by hopantenate was consistent with decreased lipid breakdown, while increased carbohydrate utilization by uridine was concomitant with decreased amino acid degradation. In this way, decreased cerebral carbohydrate utilization by 6-amino-nicotinamide was associated with increased lipid and amino acid breakdown. Furthermore, the increased loss of cerebral phospholipids and phospholipid-bound fatty acids by L-acetylcarnitine occurred in the presence of a large glucose availability and was associated with an extensive reduction of cerebral glycolytic flux.

MeSH Terms
6-Aminonicotinamide/therapeutic use Acetylcarnitine/therapeutic use Animals Cerebral Cortex/metabolism Energy Metabolism Hypoglycemia/drug therapy,metabolism Male Pantothenic Acid/analogs & derivatives,therapeutic use Rats Rats, Inbred Strains Uridine/therapeutic use gamma-Aminobutyric Acid/analogs & derivatives,therapeutic use
Chemicals
pantogab Pantothenic Acid 6-Aminonicotinamide gamma-Aminobutyric Acid Acetylcarnitine Uridine
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Benzi G
Villa R F
Dossena M
Vercesi L
Gorini A
Pastoris O
Article Info
Journal
Journal of neuroscience research
Abbr.
J Neurosci Res
ISSN
0360-4012
Published
1984-00-00
Pages
437-50
Language
English
Region
United States
NLM ID
7600111
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]